Safety and Preliminary Efficacy of SNK01 in Combination With Trastuzumab or Cetuximab in Subjects With Advanced HER2 or EGFR Cancers
NKGen Biotech, Inc.
NKGen Biotech, Inc.
University of Alabama at Birmingham
Hadassah Medical Organization
Children's Oncology Group
Mayo Clinic
Enzon Pharmaceuticals, Inc.
M.D. Anderson Cancer Center